Rett Syndrome Health Checklist

Rett Syndrome Health Checklist (UK, 2019)

The Rett syndrome Health Checklist provides information to help with symptom identification and management, including suggestions for drugs which may help and those which may cause difficulties for people with Rett syndrome. There are also links to relevant research papers, case studies, and best practice guidance.

Many thanks to everyone who has contributed to this important document and to The Bolland Charitable Fund for their support.

View here

The UK Rett Syndrome Health Checklist was developed in 2019 through collaborative work between Reverse Rett, Rett UK, FOXG1 UK and the UK Rett Disorders Working Group. This group brought together clinicians, therapists, consultants, and experts by experience, including families, caregivers, and patient organisations.

That alliance concluded in 2024. Reverse Rett now operates independently, maintaining its own evidence base and strategic positions on disease burden and advocacy.

The clinical and practical guidance contained within the Health Checklist remains valid and continues to be a useful resource for families caring for a person with Rett syndrome.

 

We hope you will find this a key ‘go to’ document to advocate for the best care and treatment for your daughter or son.

Please share it with key people involved in their care.

Request yours now

If you would like a copy of the Rett Syndrome Health Checklist, please fill out the form below and we will send one in due 7-10 working days. Any enquiries, please email [email protected]

    Your Details

     

    Contact Details

    Latest news

    View: All
    • Reverse Rett Launches Medical & Scientific Advisory Board

      Reverse Rett Launches Medical & Scientific Advisory Board

      We are pleased to announce the formal launch of the Reverse Rett Medical &
      Read More
    • We are Hiring 

      We are Hiring 

      Community Fundraising & Advocacy Manager Reverse Rett   Hours: 35 hours per week (permanent)  Holidays: 28 days
      Read More
    • Daybue Rejected by the EU: What This Means for Families and Why Patient Advocacy Matters

      Daybue Rejected by the EU: What This Means for Families and Why Patient Advocacy Matters

      The European Medicines Agency has rejected Daybue for Rett syndrome. We explain why and what this means for families and future treatments.
      Read More